Dr. Guarino is an anthropologist who specializes in mixed-methods research on drug use and HIV/HCV infection. She has expertise in the development and evaluation of behavioral interventions, especially technology-based interventions, for drug users in urban settings.
Dr. Guarino has served as Principal Investigator or Co-Investigator on numerous federally-funded studies with a broad range of drug-using populations in New York City, including young adults who use opioids, people who inject drugs, immigrants, individuals in methadone maintenance treatment and chronic pain patients. She was previously the Director of the Center for Technology and Health at National Development and Research Institutes in New York City and is an Affiliated Investigator with the Center for Drug Use and HIV/HCV Research at the NYU School of Global Public Health and the Center for Technology and Behavioral Health at Dartmouth College.
Her work bears on implementation science by examining how multi-level contextual factors influence the uptake and effectiveness of evidence-based interventions and how these factors can be leveraged to improve the accessibility, acceptability and sustainability of interventions to reduce the negative health impacts of drug use.
Palamar JJ, Le A, Guarino H, Mateu-Gelabert P. A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users. Drug Alcohol Depend. 2019 May 22;200:161-167. doi: 10.1016/j.drugalcdep.2019.04.008. [Epub ahead of print]
Friedman SR, Williams L, Young AM, Teubl J, Paraskevis D, Kostaki E, Latkin C, German D, Mateu-Gelabert P, Guarino H, Vasylyeva TI, Skaathun B, Schneider J, Korobchuk A, Smyrnov P, Nikolopoulos G. Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics. Curr HIV/AIDS Rep. 2018 Jun;15(3):283-292. doi: 10.1007/s11904-018-0403-2.
Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018 Nov;86:118-123. doi: 10.1016/j.addbeh.2018.04.017. Epub 2018 May 1.
Quinn K, Fong C, Guarino H, Mateu-Gelabert P. Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City. Drug Alcohol Depend. 2019 Jan 1;194:453-459. doi: 10.1016/j.drugalcdep.2018.11.010. Epub 2018 Nov 28.
Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, Berbesi D, Toro-Tobón D, Goodbody E, Ompad DC, Friedman SR. Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention. Curr HIV/AIDS Rep. 2018 Aug;15(4):324-335. doi: 10.1007/s11904-018-0406-z.